Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × RNA, Messenger × Clear all

NCT02452307 2017-08-17

Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy

Phase 1/2 Unknown

Prostatic Neoplasms